NCT04237922View on ClinicalTrials.gov

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

CompletedOBSERVATIONAL
Enrollment

43,864

Participants

Timeline

Start Date

September 22, 2019

Primary Completion Date

February 18, 2021

Study Completion Date

February 18, 2021

Conditions
Antiplatelet
Interventions
DRUG

Prasugrel 10mg

Prasugrel 10mg dispensing claim is used as the exposure group

DRUG

Clopidogrel 75mg

Clopidogrel 75 mg dispensing claim is used as the reference group

Trial Locations (1)

02120

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT04237922 - Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data | Biotech Hunter | Biotech Hunter